Saxonov Serge

Chief Executive Officer

Saxonov Serge has filed 14 SEC Form 4 filings (27 transaction rows) across 1 company, with disclosures dating back to 2025. 13 of those filings fall inside the rolling window. Most recent filing: Sep 24, 2026.

On the most recent filing, Saxonov Serge is listed as Chief Executive Officer at 10x Genomics, Inc. Inside the rolling window, Saxonov Serge reported no open-market purchases and 11 open-market sales totaling $6.6M in TXG. The largest disclosed transaction in the window is a sale of 25,000 TXG shares on Sep 22, 2026, worth $2.0M.

Companies traded

Other insiders at TXG

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$6.6M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TXGSale$2.0MSep 24SEC ↗
TXGSale$668KAug 28SEC ↗
TXGSale$1.2MAug 26SEC ↗
TXGSale$1.0MJun 24SEC ↗
TXGSale$444KMay 27SEC ↗
TXGSale$265KMay 27SEC ↗
TXGSale$123KApr 16SEC ↗
TXGSale$191KMar 25SEC ↗
TXGSale$98KMar 25SEC ↗
TXGSale$367KMar 4SEC ↗
TXGSale$252KNov 25SEC ↗
Showing 1–11 of 11
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Saxonov Serge made?

Saxonov Serge has filed 14 SEC Form 4 filings (27 transaction rows) across 1 company since 2025.

Which companies does Saxonov Serge trade?

Saxonov Serge has filed SEC Form 4 disclosures for 1 company, including TXG.

When was Saxonov Serge's most recent SEC Form 4 filing?

Saxonov Serge's most recent SEC Form 4 filing on Tracefour is dated Sep 24, 2026.

What is Saxonov Serge's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Saxonov Serge is listed as Chief Executive Officer.

What is Saxonov Serge's total buy and sell value in the current window?

Inside the rolling retention window, Saxonov Serge bought $0 and sold $6.6M based on SEC Form 4 filings.

What was Saxonov Serge's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 25,000 TXG shares on 2026-09-22, worth $2.0M, per SEC Form 4 filings.